Global Bio Pharma Buffer Market Insights and Forecast to 2027

Publisher Name :
Date: 06-May-2021
No. of pages: 111
Inquire Before Buying

Bio Pharma Buffer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type

- Phosphates Buffer

- Acetates Buffer

- TRIS Buffer

- Others

Segment by Application

- Research Institution

- Pharmaceutical Industry

- Others

By Company

- Avantor

- Alfa Aesar (Thermo Fisher)

- Merck

- Lonza

- Bio-Rad

- BD

- GE Healthcare

- Promega Corporation

- Hamilton Company

- XZL BIO-TECHNOLOGY

- SRL

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

Global Bio Pharma Buffer Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Market by Type
1.2.1 Global Bio Pharma Buffer Market Size Growth Rate by Type
1.4.2 Phosphates Buffer
1.4.3 Acetates Buffer
1.2.4 TRIS Buffer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio Pharma Buffer Market Size Growth Rate by Application
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bio Pharma Buffer Sales Estimates and Forecasts 2016-2027
2.2 Global Bio Pharma Buffer Revenue Estimates and Forecasts 2016-2027
2.3 Global Bio Pharma Buffer Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Bio Pharma Buffer Regions by Sales
2.4.1 Global Top Bio Pharma Buffer Regions by Sales (2016-2021)
2.4.2 Global Top Bio Pharma Buffer Regions by Sales (2022-2027)
2.5 Global Top Bio Pharma Buffer Regions by Revenue
2.5.1 Global Top Bio Pharma Buffer Regions by Revenue (2016-2021)
2.5.2 Global Top Bio Pharma Buffer Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bio Pharma Buffer Sales by Manufacturers
3.1.1 Global Top Bio Pharma Buffer Manufacturers by Sales (2016-2021)
3.1.2 Global Top Bio Pharma Buffer Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Bio Pharma Buffer Sales in 2020
3.2 Global Bio Pharma Buffer Revenue by Manufacturers
3.2.1 Global Top Bio Pharma Buffer Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Bio Pharma Buffer Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Bio Pharma Buffer Revenue in 2020
3.3 Global Bio Pharma Buffer Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bio Pharma Buffer Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bio Pharma Buffer Sales by Type
4.1.1 Global Bio Pharma Buffer Historical Sales by Type (2016-2021)
4.1.2 Global Bio Pharma Buffer Forecasted Sales by Type (2022-2027)
4.1.3 Global Bio Pharma Buffer Sales Market Share by Type (2016-2027)
4.2 Global Bio Pharma Buffer Revenue by Type
4.2.1 Global Bio Pharma Buffer Historical Revenue by Type (2016-2021)
4.2.2 Global Bio Pharma Buffer Forecasted Revenue by Type (2022-2027)
4.2.3 Global Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
4.3 Global Bio Pharma Buffer Price by Type
4.3.1 Global Bio Pharma Buffer Price by Type (2016-2021)
4.3.2 Global Bio Pharma Buffer Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Bio Pharma Buffer Sales by Application
5.1.1 Global Bio Pharma Buffer Historical Sales by Application (2016-2021)
5.1.2 Global Bio Pharma Buffer Forecasted Sales by Application (2022-2027)
5.1.3 Global Bio Pharma Buffer Sales Market Share by Application (2016-2027)
5.2 Global Bio Pharma Buffer Revenue by Application
5.2.1 Global Bio Pharma Buffer Historical Revenue by Application (2016-2021)
5.2.2 Global Bio Pharma Buffer Forecasted Revenue by Application (2022-2027)
5.2.3 Global Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
5.3 Global Bio Pharma Buffer Price by Application
5.3.1 Global Bio Pharma Buffer Price by Application (2016-2021)
5.3.2 Global Bio Pharma Buffer Price Forecast by Application (2022-2027)
6 North America
6.1 North America Bio Pharma Buffer Market Size by Type
6.1.1 North America Bio Pharma Buffer Sales by Type (2016-2027)
6.1.2 North America Bio Pharma Buffer Revenue by Type (2016-2027)
6.2 North America Bio Pharma Buffer Market Size by Application
6.2.1 North America Bio Pharma Buffer Sales by Application (2016-2027)
6.2.2 North America Bio Pharma Buffer Revenue by Application (2016-2027)
6.3 North America Bio Pharma Buffer Market Size by Country
6.3.1 North America Bio Pharma Buffer Sales by Country (2016-2027)
6.3.2 North America Bio Pharma Buffer Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bio Pharma Buffer Market Size by Type
7.1.1 Europe Bio Pharma Buffer Sales by Type (2017-2027)
7.1.2 Europe Bio Pharma Buffer Revenue by Type (2017-2027)
7.2 Europe Bio Pharma Buffer Market Size by Application
7.2.1 Europe Bio Pharma Buffer Sales by Application (2017-2027)
7.2.2 Europe Bio Pharma Buffer Revenue by Application (2017-2027)
7.3 Europe Bio Pharma Buffer Market Size by Country
7.3.1 Europe Bio Pharma Buffer Sales by Country (2017-2027)
7.3.2 Europe Bio Pharma Buffer Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bio Pharma Buffer Market Size by Type
8.1.1 Asia Pacific Bio Pharma Buffer Sales by Type (2018-2027)
8.1.2 Asia Pacific Bio Pharma Buffer Revenue by Type (2018-2027)
8.2 Asia Pacific Bio Pharma Buffer Market Size by Application
8.2.1 Asia Pacific Bio Pharma Buffer Sales by Application (2018-2027)
8.2.2 Asia Pacific Bio Pharma Buffer Revenue by Application (2018-2027)
8.3 Asia Pacific Bio Pharma Buffer Market Size by Region
8.3.1 Asia Pacific Bio Pharma Buffer Sales by Region (2018-2027)
8.3.2 Asia Pacific Bio Pharma Buffer Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bio Pharma Buffer Market Size by Type
9.1.1 Latin America Bio Pharma Buffer Sales by Type (2019-2027)
9.1.2 Latin America Bio Pharma Buffer Revenue by Type (2019-2027)
9.2 Latin America Bio Pharma Buffer Market Size by Application
9.2.1 Latin America Bio Pharma Buffer Sales by Application (2019-2027)
9.2.2 Latin America Bio Pharma Buffer Revenue by Application (2019-2027)
9.3 Latin America Bio Pharma Buffer Market Size by Country
9.3.1 Latin America Bio Pharma Buffer Sales by Country (2019-2027)
9.3.2 Latin America Bio Pharma Buffer Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Bio Pharma Buffer Market Size by Type
6.1.1 Middle East and Africa Bio Pharma Buffer Sales by Type (2016-2027)
6.1.2 Middle East and Africa Bio Pharma Buffer Revenue by Type (2016-2027)
6.2 Middle East and Africa Bio Pharma Buffer Market Size by Application
6.2.1 Middle East and Africa Bio Pharma Buffer Sales by Application (2016-2027)
6.2.2 Middle East and Africa Bio Pharma Buffer Revenue by Application (2016-2027)
6.3 Middle East and Africa Bio Pharma Buffer Market Size by Country
6.3.1 Middle East and Africa Bio Pharma Buffer Sales by Country (2016-2027)
6.3.2 Middle East and Africa Bio Pharma Buffer Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Avantor
11.1.1 Avantor Corporation Information
11.1.2 Avantor Overview
11.1.3 Avantor Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Avantor Bio Pharma Buffer Product Description
11.1.5 Avantor Related Developments
11.2 Alfa Aesar (Thermo Fisher)
11.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
11.2.2 Alfa Aesar (Thermo Fisher) Overview
11.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Description
11.2.5 Alfa Aesar (Thermo Fisher) Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Bio Pharma Buffer Product Description
11.3.5 Merck Related Developments
11.4 Lonza
11.4.1 Lonza Corporation Information
11.4.2 Lonza Overview
11.4.3 Lonza Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Lonza Bio Pharma Buffer Product Description
11.4.5 Lonza Related Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Corporation Information
11.5.2 Bio-Rad Overview
11.5.3 Bio-Rad Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Bio-Rad Bio Pharma Buffer Product Description
11.5.5 Bio-Rad Related Developments
11.6 BD
11.6.1 BD Corporation Information
11.6.2 BD Overview
11.6.3 BD Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 BD Bio Pharma Buffer Product Description
11.6.5 BD Related Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Corporation Information
11.7.2 GE Healthcare Overview
11.7.3 GE Healthcare Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 GE Healthcare Bio Pharma Buffer Product Description
11.7.5 GE Healthcare Related Developments
11.8 Promega Corporation
11.8.1 Promega Corporation Corporation Information
11.8.2 Promega Corporation Overview
11.8.3 Promega Corporation Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Promega Corporation Bio Pharma Buffer Product Description
11.8.5 Promega Corporation Related Developments
11.9 Hamilton Company
11.9.1 Hamilton Company Corporation Information
11.9.2 Hamilton Company Overview
11.9.3 Hamilton Company Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Hamilton Company Bio Pharma Buffer Product Description
11.9.5 Hamilton Company Related Developments
11.10 XZL BIO-TECHNOLOGY
11.10.1 XZL BIO-TECHNOLOGY Corporation Information
11.10.2 XZL BIO-TECHNOLOGY Overview
11.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Description
11.10.5 XZL BIO-TECHNOLOGY Related Developments
11.1 Avantor
11.1.1 Avantor Corporation Information
11.1.2 Avantor Overview
11.1.3 Avantor Bio Pharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Avantor Bio Pharma Buffer Product Description
11.1.5 Avantor Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Bio Pharma Buffer Value Chain Analysis
12.2 Bio Pharma Buffer Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bio Pharma Buffer Production Mode & Process
12.4 Bio Pharma Buffer Sales and Marketing
12.4.1 Bio Pharma Buffer Sales Channels
12.4.2 Bio Pharma Buffer Distributors
12.5 Bio Pharma Buffer Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bio Pharma Buffer Industry Trends
13.2 Bio Pharma Buffer Market Drivers
13.3 Bio Pharma Buffer Market Challenges
13.4 Bio Pharma Buffer Market Restraints
14 Key Findings in The Global Bio Pharma Buffer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bio Pharma Buffer Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Phosphates Buffer
Table 3. Major Manufacturers of Acetates Buffer
Table 4. Major Manufacturers of TRIS Buffer
Table 5. Major Manufacturers of Others
Table 6. Global Bio Pharma Buffer Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Bio Pharma Buffer Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 9. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Table 10. Global Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 11. Global Bio Pharma Buffer Sales Market Share by Region (2022-2027)
Table 12. Global Bio Pharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Bio Pharma Buffer Revenue Market Share by Region (2016-2021)
Table 14. Global Bio Pharma Buffer Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Bio Pharma Buffer Revenue Market Share by Region (2022-2027)
Table 16. Global Bio Pharma Buffer Sales by Manufacturers (2016-2021) & (K Liter)
Table 17. Global Bio Pharma Buffer Sales Share by Manufacturers (2016-2021)
Table 18. Global Bio Pharma Buffer Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Bio Pharma Buffer Revenue Share by Manufacturers (2016-2021)
Table 20. Bio Pharma Buffer Price by Manufacturers 2016-2021 (USD/Liter)
Table 21. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2020)
Table 23. Bio Pharma Buffer Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Bio Pharma Buffer Product Offered
Table 25. Date of Manufacturers Enter into Bio Pharma Buffer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 28. Global Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 29. Global Bio Pharma Buffer Sales Share by Type (2016-2021)
Table 30. Global Bio Pharma Buffer Sales Share by Type (2022-2027)
Table 31. Global Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Bio Pharma Buffer Revenue Share by Type (2016-2021)
Table 34. Global Bio Pharma Buffer Revenue Share by Type (2022-2027)
Table 35. Bio Pharma Buffer Price by Type (2016-2021) & (USD/Liter)
Table 36. Global Bio Pharma Buffer Price Forecast by Type (2022-2027) & (USD/Liter)
Table 37. Global Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 38. Global Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 39. Global Bio Pharma Buffer Sales Share by Application (2016-2021)
Table 40. Global Bio Pharma Buffer Sales Share by Application (2022-2027)
Table 41. Global Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Bio Pharma Buffer Revenue Share by Application (2016-2021)
Table 44. Global Bio Pharma Buffer Revenue Share by Application (2022-2027)
Table 45. Bio Pharma Buffer Price by Application (2016-2021) & (USD/Liter)
Table 46. Global Bio Pharma Buffer Price Forecast by Application (2022-2027) & (USD/Liter)
Table 47. North America Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 48. North America Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 49. North America Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 52. North America Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 53. North America Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 56. North America Bio Pharma Buffer Sales by Country (2022-2027) & (K Liter)
Table 57. North America Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Bio Pharma Buffer Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 60. Europe Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 61. Europe Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 64. Europe Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 65. Europe Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 68. Europe Bio Pharma Buffer Sales by Country (2022-2027) & (K Liter)
Table 69. Europe Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Bio Pharma Buffer Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 72. Asia Pacific Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 73. Asia Pacific Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 76. Asia Pacific Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 77. Asia Pacific Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Bio Pharma Buffer Sales by Region (2016-2021) & (K Liter)
Table 80. Asia Pacific Bio Pharma Buffer Sales by Region (2022-2027) & (K Liter)
Table 81. Asia Pacific Bio Pharma Buffer Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Bio Pharma Buffer Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 84. Latin America Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 85. Latin America Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 88. Latin America Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 89. Latin America Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 92. Latin America Bio Pharma Buffer Sales by Country (2022-2027) & (K Liter)
Table 93. Latin America Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Bio Pharma Buffer Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Bio Pharma Buffer Sales by Type (2016-2021) & (K Liter)
Table 96. Middle East and Africa Bio Pharma Buffer Sales by Type (2022-2027) & (K Liter)
Table 97. Middle East and Africa Bio Pharma Buffer Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Bio Pharma Buffer Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Bio Pharma Buffer Sales by Application (2016-2021) & (K Liter)
Table 100. Middle East and Africa Bio Pharma Buffer Sales by Application (2022-2027) & (K Liter)
Table 101. Middle East and Africa Bio Pharma Buffer Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Bio Pharma Buffer Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Bio Pharma Buffer Sales by Country (2016-2021) & (K Liter)
Table 104. Middle East and Africa Bio Pharma Buffer Sales by Country (2022-2027) & (K Liter)
Table 105. Middle East and Africa Bio Pharma Buffer Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Bio Pharma Buffer Revenue by Country (2022-2027) & (US$ Million)
Table 107. Avantor Corporation Information
Table 108. Avantor Description and Major Businesses
Table 109. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 110. Avantor Bio Pharma Buffer Product
Table 111. Avantor Recent Developments
Table 112. Alfa Aesar (Thermo Fisher) Corporation Information
Table 113. Alfa Aesar (Thermo Fisher) Description and Major Businesses
Table 114. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 115. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
Table 116. Alfa Aesar (Thermo Fisher) Recent Developments
Table 117. Merck Corporation Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 120. Merck Bio Pharma Buffer Product
Table 121. Merck Recent Developments
Table 122. Lonza Corporation Information
Table 123. Lonza Description and Major Businesses
Table 124. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 125. Lonza Bio Pharma Buffer Product
Table 126. Lonza Recent Developments
Table 127. Bio-Rad Corporation Information
Table 128. Bio-Rad Description and Major Businesses
Table 129. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 130. Bio-Rad Bio Pharma Buffer Product
Table 131. Bio-Rad Recent Developments
Table 132. BD Corporation Information
Table 133. BD Description and Major Businesses
Table 134. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 135. BD Bio Pharma Buffer Product
Table 136. BD Recent Developments
Table 137. GE Healthcare Corporation Information
Table 138. GE Healthcare Description and Major Businesses
Table 139. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 140. GE Healthcare Bio Pharma Buffer Product
Table 141. GE Healthcare Recent Developments
Table 142. Promega Corporation Corporation Information
Table 143. Promega Corporation Description and Major Businesses
Table 144. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 145. Promega Corporation Bio Pharma Buffer Product
Table 146. Promega Corporation Recent Developments
Table 147. Hamilton Company Corporation Information
Table 148. Hamilton Company Description and Major Businesses
Table 149. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 150. Hamilton Company Bio Pharma Buffer Product
Table 151. Hamilton Company Recent Developments
Table 152. XZL BIO-TECHNOLOGY Corporation Information
Table 153. XZL BIO-TECHNOLOGY Description and Major Businesses
Table 154. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 155. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
Table 156. XZL BIO-TECHNOLOGY Recent Developments
Table 157. SRL Corporation Information
Table 158. SRL Description and Major Businesses
Table 159. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2016-2021)
Table 160. SRL Bio Pharma Buffer Product
Table 161. SRL Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Bio Pharma Buffer Distributors List
Table 165. Bio Pharma Buffer Customers List
Table 166. Bio Pharma Buffer Market Trends
Table 167. Bio Pharma Buffer Market Drivers
Table 168. Bio Pharma Buffer Market Challenges
Table 169. Bio Pharma Buffer Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Market Share by Type in 2020 & 2027
Figure 3. Phosphates Buffer Product Picture
Figure 4. Acetates Buffer Product Picture
Figure 5. TRIS Buffer Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bio Pharma Buffer Sales Market Share by Application in 2020 & 2027
Figure 8. Research Institution
Figure 9. Pharmaceutical Industry
Figure 10. Others
Figure 11. Bio Pharma Buffer Report Years Considered
Figure 12. Global Bio Pharma Buffer Sales 2016-2027 (K Liter)
Figure 13. Global Bio Pharma Buffer Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bio Pharma Buffer Revenue 2016-2027 (US$ Million)
Figure 15. Global Bio Pharma Buffer Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Bio Pharma Buffer Sales Market Share by Region (2016-2021)
Figure 17. Global Bio Pharma Buffer Sales Market Share by Region (2022-2027)
Figure 18. North America Bio Pharma Buffer Sales YoY (2016-2027) & (K Liter)
Figure 19. North America Bio Pharma Buffer Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Bio Pharma Buffer Sales YoY (2016-2027) & (K Liter)
Figure 21. Europe Bio Pharma Buffer Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Bio Pharma Buffer Sales YoY (2016-2027) & (K Liter)
Figure 23. Asia-Pacific Bio Pharma Buffer Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Bio Pharma Buffer Sales YoY (2016-2027) & (K Liter)
Figure 25. Latin America Bio Pharma Buffer Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Bio Pharma Buffer Sales YoY (2016-2027) & (K Liter)
Figure 27. Middle East & Africa Bio Pharma Buffer Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Bio Pharma Buffer Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Bio Pharma Buffer Revenue in 2020
Figure 30. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 32. Global Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 33. Global Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 34. Global Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 35. North America Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 36. North America Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 37. North America Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 38. North America Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 39. North America Bio Pharma Buffer Sales Share by Country (2016-2027)
Figure 40. North America Bio Pharma Buffer Revenue Share by Country (2016-2027)
Figure 41. U.S. Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 44. Europe Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 45. Europe Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 46. Europe Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 47. Europe Bio Pharma Buffer Sales Share by Country (2016-2027)
Figure 48. Europe Bio Pharma Buffer Revenue Share by Country (2016-2027)
Figure 49. Germany Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 50. France Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Bio Pharma Buffer Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Bio Pharma Buffer Revenue Share by Region (2016-2027)
Figure 60. China Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 63. India Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 65. Taiwan Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 69. Philippines Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 71. Latin America Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 73. Latin America Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Bio Pharma Buffer Sales Share by Country (2016-2027)
Figure 75. Latin America Bio Pharma Buffer Revenue Share by Country (2016-2027)
Figure 76. Mexico Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Bio Pharma Buffer Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Bio Pharma Buffer Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Bio Pharma Buffer Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Bio Pharma Buffer Sales Share by
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs